# Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol

> **NCT02592096** · PHASE1 · UNKNOWN · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 32 (estimated)

## Conditions studied

- Otitis Media

## Interventions

- **DRUG:** 0.1% Pazufloxacin Mesilate Ear Drops
- **DRUG:** 0.3% Pazufloxacin Mesilate Ear Drops
- **DRUG:** 0.5% Pazufloxacin Mesilate Ear Drops
- **DRUG:** Pazufloxacin mesilate injection

## Key facts

- **NCT ID:** NCT02592096
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2016-01
- **Final completion:** 2016-02
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2015-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02592096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02592096, "Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02592096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*